TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

Thursday’s trading has closed, but TXMD is being traded in the after-hours session. After-Hours quote »
6.73
Delayed Data
As of 4:00pm ET
 +0.11 / +1.66%
Today’s Change
3.44
Today|||52-Week Range
7.49
+51.24%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close6.62
Today’s open6.61
Day’s range6.46 - 6.75
Volume578,958
Average volume (3 months)1,360,275
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)-63.64%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+71.23%
P/E ratioNM
Price/Sales44.34
Price/Book21.36

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.23+1.92%
PDLIPDL BioPharma Inc+0.08+1.19%
ACHNAchillion Pharmaceut...-0.02-0.21%
EBSEmergent BioSolution...+0.73+2.35%
Data as of 4:03pm ET, 05/28/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$15.0M
Annual profit (last year)-$54.2M
Net profit margin-360.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President, Secretary &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers